FDA.reportPublic FDA data

Requip XL 2 MG 24HR Extended Release Oral Tablet

RxCUI
799832
RxNorm name
Requip XL 2 MG 24HR Extended Release Oral Tablet
Display name
Requip XL 2 MG 24HR Extended Release Oral Tablet
Full name
Requip XL 2 MG 24HR Extended Release Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2deb758c-659e-4e5a-a087-0e9c422f2fe1REQUIP XL 2 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR ropinirole 2 MG Extended Release Oral Tablet [Requip] [SBD] · 24 HR Requip XL 2 MG Extended Release Oral Tablet [SY] · Requip XL 2 MG 24HR Extended Release Oral Tablet [SY]45These highlights do not include all the information needed to use REQUIP XL safely and effectively. See full prescribing information for REQUIP XL. REQUIP XL (ropinirole extended-release tablets) Initial U.S. Approval: 199720111227